ArticleJournal of geriatric cardiology : JGC2025

Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.

Mei Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.